{
  "DOI": "10.1007/s10689-018-0070-x",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-018-0070-x",
  "alternative-id": [
    "70"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "14 February 2018"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Dr. Olufunmilayo Olopade is co-founder of CancerIQ. All co-authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "West",
      "given": "Allison H.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Blazer",
      "given": "Kathleen R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Stoll",
      "given": "Jessica",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jones",
      "given": "Matthew",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Weipert",
      "given": "Caroline M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nielsen",
      "given": "Sarah M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kupfer",
      "given": "Sonia S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Weitzel",
      "given": "Jeffrey N.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-9936-1599",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Olopade",
      "given": "Olufunmilayo I.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        2,
        14
      ]
    ],
    "date-time": "2018-02-14T08:58:08Z",
    "timestamp": 1518598688000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        5,
        14
      ]
    ],
    "date-time": "2020-05-14T06:55:12Z",
    "timestamp": 1589439312000
  },
  "funder": [
    {
      "DOI": "10.13039/100000054",
      "award": [
        "T32CA009566",
        "R13CA206594-01",
        "R25CA171998"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Cancer Institute"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        16
      ]
    ],
    "date-time": "2024-04-16T09:52:33Z",
    "timestamp": 1713261153090
  },
  "is-referenced-by-count": 15,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2018,
        2,
        14
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2018,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            2,
            14
          ]
        ],
        "date-time": "2018-02-14T00:00:00Z",
        "timestamp": 1518566400000
      }
    },
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            2,
            14
          ]
        ],
        "date-time": "2018-02-14T00:00:00Z",
        "timestamp": 1518566400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-018-0070-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-0070-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-0070-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "495-505",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2018,
        2,
        14
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        2,
        14
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "SV Hodgson",
      "edition": "3",
      "key": "70_CR1",
      "unstructured": "Hodgson SV (2007) A practical guide to human cancer genetics, 3rd edn. Cambridge University Press, New York",
      "volume-title": "A practical guide to human cancer genetics",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jncimonographs/lgn001",
      "author": "NM Lindor",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Natl Cancer Inst Monogr",
      "key": "70_CR2",
      "unstructured": "Lindor NM, McMaster ML, Lindor CJ, Greene MH (2008) Concise handbook of familial cancer susceptibility syndromes, 2nd edn. J Natl Cancer Inst Monogr 38:1–93. \n                    https://doi.org/10.1093/jncimonographs/lgn001",
      "volume": "38",
      "year": "2008"
    },
    {
      "author": "K Offit",
      "key": "70_CR3",
      "unstructured": "Offit K (1998) Clinical cancer genetics: risk counseling and management New York. Wiley Liss, New York",
      "volume-title": "Clinical cancer genetics: risk counseling and management New York",
      "year": "1998"
    },
    {
      "DOI": "10.3322/caac.20128",
      "author": "JN Weitzel",
      "doi-asserted-by": "publisher",
      "first-page": "327",
      "issue": "5",
      "journal-title": "CA Cancer J Clin",
      "key": "70_CR4",
      "unstructured": "Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K (2011) Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin 61(5):327–359. \n                    https://doi.org/10.3322/caac.20128",
      "volume": "61",
      "year": "2011"
    },
    {
      "DOI": "10.1053/j.seminoncol.2007.07.003",
      "author": "TA DeMarco",
      "doi-asserted-by": "publisher",
      "first-page": "369",
      "issue": "5",
      "journal-title": "Semin Oncol",
      "key": "70_CR5",
      "unstructured": "DeMarco TA, Smith KL, Nusbaum RH, Peshkin BN, Schwartz MD, Isaacs C (2007) Practical aspects of delivering hereditary cancer risk counseling. Semin Oncol 34(5): 369–378. \n                    https://doi.org/10.1053/j.seminoncol.2007.07.003",
      "volume": "34",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmg.2003.010918",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "issue": "2",
      "journal-title": "J Med Genet",
      "key": "70_CR6",
      "unstructured": "Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81–91",
      "volume": "41",
      "year": "2004"
    },
    {
      "key": "70_CR7",
      "unstructured": "National Comprehensive Cancer Network (NCCN) (2016). Genetic/familial high-risk assessment: breast and ovarian version 2"
    },
    {
      "DOI": "10.1038/sj.onc.1210872",
      "author": "JH Lee",
      "doi-asserted-by": "publisher",
      "first-page": "7741",
      "issue": "56",
      "journal-title": "Oncogene",
      "key": "70_CR8",
      "unstructured": "Lee JH, Paull TT (2007) Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26(56):7741–7748. \n                    https://doi.org/10.1038/sj.onc.1210872",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1002/gcc.20101",
      "author": "E Cavaciuti",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "70_CR9",
      "unstructured": "Cavaciuti E, Lauge A, Janin N et al (2005) Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosomes Cancer 42(1):1–9. \n                    https://doi.org/10.1002/gcc.20101",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng1837",
      "author": "A Renwick",
      "doi-asserted-by": "publisher",
      "first-page": "873",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "70_CR10",
      "unstructured": "Renwick A, Thompson D, Seal S et al (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875. \n                    https://doi.org/10.1038/ng1837",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jnci/dji141",
      "author": "D Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "813",
      "issue": "11",
      "journal-title": "J Natl Cancer Inst",
      "key": "70_CR11",
      "unstructured": "Thompson D, Duedal S, Kirner J et al. (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97(11):813–822. \n                    https://doi.org/10.1093/jnci/dji141",
      "volume": "97",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJMsr1501341",
      "author": "DF Easton",
      "doi-asserted-by": "publisher",
      "first-page": "2243",
      "issue": "23",
      "journal-title": "New Engl J Med",
      "key": "70_CR12",
      "unstructured": "Easton DF, Pharoah PD, Antoniou AC et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. New Engl J Med 372(23):2243–2257. \n                    https://doi.org/10.1056/NEJMsr1501341",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1200/jco.2015.65.0747",
      "author": "N Tung",
      "doi-asserted-by": "publisher",
      "first-page": "1460",
      "issue": "13",
      "journal-title": "J Clin Oncol",
      "key": "70_CR13",
      "unstructured": "Tung N, Lin NU, Kidd J et al (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34(13):1460–1468. \n                    https://doi.org/10.1200/jco.2015.65.0747",
      "volume": "34",
      "year": "2016"
    },
    {
      "key": "70_CR14",
      "unstructured": "National Comprehensive Cancer Network (NCCN) (2015). Genetic/familial high-risk assessment: colorectal. Version 2"
    },
    {
      "DOI": "10.1038/ng879",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "issue": "1",
      "journal-title": "Nat Genet",
      "key": "70_CR15",
      "unstructured": "Meijers-Heijboer H, van den Ouweland A, Klijn J et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55–59. \n                    https://doi.org/10.1038/ng879",
      "volume": "31",
      "year": "2002"
    },
    {
      "author": "SB Lee",
      "first-page": "8062",
      "issue": "22",
      "journal-title": "Cancer Res",
      "key": "70_CR16",
      "unstructured": "Lee SB, Kim SH, Bell DW et al (2001) Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni syndrome. Cancer Res 61(22):8062–8067",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1086/341943",
      "author": "P Vahteristo",
      "doi-asserted-by": "publisher",
      "first-page": "432",
      "issue": "2",
      "journal-title": "Am J Hum Genet",
      "key": "70_CR17",
      "unstructured": "Vahteristo P, Bartkova J, Eerola H et al (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71(2):432–438. \n                    https://doi.org/10.1086/341943",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1002/ijc.25003",
      "author": "J Suchy",
      "doi-asserted-by": "publisher",
      "first-page": "3005",
      "issue": "12",
      "journal-title": "Int J Cancer",
      "key": "70_CR18",
      "unstructured": "Suchy J, Cybulski C, Wokolorczyk D et al (2010) CHEK2 mutations and HNPCC-related colorectal cancer. Int J Cancer 126(12):3005–3009. \n                    https://doi.org/10.1002/ijc.25003",
      "volume": "126",
      "year": "2010"
    },
    {
      "DOI": "10.1086/426403",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "1131",
      "issue": "6",
      "journal-title": "Am J Hum Genet",
      "key": "70_CR19",
      "unstructured": "Cybulski C, Gorski B, Huzarski T et al (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75(6):1131–1135. \n                    https://doi.org/10.1086/426403",
      "volume": "75",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.bjc.6605038",
      "author": "J Gronwald",
      "doi-asserted-by": "publisher",
      "first-page": "1508",
      "issue": "9",
      "journal-title": "Br J Cancer",
      "key": "70_CR20",
      "unstructured": "Gronwald J, Cybulski C, Piesiak W et al (2009) Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband. Br J Cancer 100(9):1508–1512. \n                    https://doi.org/10.1038/sj.bjc.6605038",
      "volume": "100",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nrclinonc.2016.90",
      "author": "N Tung",
      "doi-asserted-by": "publisher",
      "first-page": "581",
      "issue": "9",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "70_CR21",
      "unstructured": "Tung N, Domchek SM, Stadler Z et al (2016) Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol 13(9):581–588. \n                    https://doi.org/10.1038/nrclinonc.2016.90",
      "volume": "13",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ijc.23026",
      "author": "DW Bell",
      "doi-asserted-by": "publisher",
      "first-page": "2661",
      "issue": "12",
      "journal-title": "Int J Cancer",
      "key": "70_CR22",
      "unstructured": "Bell DW, Kim SH, Godwin AK et al (2007) Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer 121(12):2661–2667. \n                    https://doi.org/10.1002/ijc.23026",
      "volume": "121",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.0424",
      "author": "FJ Couch",
      "doi-asserted-by": "publisher",
      "journal-title": "JAMA Oncol",
      "key": "70_CR23",
      "unstructured": "Couch FJ, Shimelis H, Hu C et al (2017) Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. \n                    https://doi.org/10.1001/jamaoncol.2017.0424",
      "year": "2017"
    },
    {
      "DOI": "10.1245/s10434-015-4754-2",
      "author": "NS Kapoor",
      "doi-asserted-by": "publisher",
      "first-page": "3282",
      "issue": "10",
      "journal-title": "Ann Surg Oncol",
      "key": "70_CR24",
      "unstructured": "Kapoor NS, Curcio LD, Blakemore CA et al (2015) Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol 22(10):3282–3288. \n                    https://doi.org/10.1245/s10434-015-4754-2",
      "volume": "22",
      "year": "2015"
    },
    {
      "DOI": "10.1097/01.GIM.0000151154.27612.49",
      "author": "KR Blazer",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "70_CR25",
      "unstructured": "Blazer KR, MacDonald DJ, Ricker C, Sand S, Uman GC, Weitzel JN (2005) Outcomes from intensive training in genetic cancer risk counseling for clinicians. Genet Med 7(1):40–47",
      "volume": "7",
      "year": "2005"
    },
    {
      "DOI": "10.1097/GIM.0b013e31821882b7",
      "author": "KR Blazer",
      "doi-asserted-by": "publisher",
      "first-page": "832",
      "issue": "9",
      "journal-title": "Genet Med",
      "key": "70_CR26",
      "unstructured": "Blazer KR, Macdonald DJ, Culver JO et al. (2011) Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce. Genet Med 13(9):832–840",
      "volume": "13",
      "year": "2011"
    },
    {
      "key": "70_CR27",
      "unstructured": "Microsoft Excel (2013) Microsoft, Redmond"
    },
    {
      "author": "JW Creswell",
      "edition": "2",
      "first-page": "208",
      "key": "70_CR28",
      "unstructured": "Creswell JW (2003) Mixed Methods procedures. Research design qualitative, quantitative, and mixed method approaches, 2nd edn. Sage, Thousand Oaks, pp 208–225",
      "volume-title": "Mixed Methods procedures. Research design qualitative, quantitative, and mixed method approaches",
      "year": "2003"
    },
    {
      "DOI": "10.1002/1097-0142(19940201)73:3\u003c643::AID-CNCR2820730323\u003e3.0.CO;2-5",
      "author": "EB Claus",
      "doi-asserted-by": "publisher",
      "first-page": "643",
      "issue": "3",
      "journal-title": "Cancer",
      "key": "70_CR29",
      "unstructured": "Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73(3):643–651",
      "volume": "73",
      "year": "1994"
    },
    {
      "DOI": "10.1093/jnci/90.18.1371",
      "author": "B Fisher",
      "doi-asserted-by": "publisher",
      "first-page": "1371",
      "issue": "18",
      "journal-title": "J Natl Cancer Inst",
      "key": "70_CR30",
      "unstructured": "Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371–1388",
      "volume": "90",
      "year": "1998"
    },
    {
      "key": "70_CR31",
      "unstructured": "National Comprehensive Cancer Network (NCCN) (2017) Breast Cancer Screening and Diagnosis. Version 1"
    },
    {
      "DOI": "10.1158/2159-8290.cd-11-0194",
      "author": "NJ Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "issue": "1",
      "journal-title": "Cancer Discov",
      "key": "70_CR32",
      "unstructured": "Roberts NJ, Jiao Y, Yu J et al. (2012) ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2(1):41–46. \n                    https://doi.org/10.1158/2159-8290.cd-11-0194",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1053/j.seminoncol.2016.09.002",
      "author": "GM Petersen",
      "doi-asserted-by": "publisher",
      "first-page": "548",
      "issue": "5",
      "journal-title": "Semin Oncol",
      "key": "70_CR33",
      "unstructured": "Petersen GM (2016) Familial pancreatic cancer. Semin Oncol 43(5):548–553. \n                    https://doi.org/10.1053/j.seminoncol.2016.09.002",
      "volume": "43",
      "year": "2016"
    },
    {
      "DOI": "10.1136/gutjnl-2012-303108",
      "author": "MI Canto",
      "doi-asserted-by": "publisher",
      "first-page": "339",
      "issue": "3",
      "journal-title": "Gut",
      "key": "70_CR34",
      "unstructured": "Canto MI, Harinck F, Hruban RH et al. (2013) International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62(3):339–347. \n                    https://doi.org/10.1136/gutjnl-2012-303108",
      "volume": "62",
      "year": "2013"
    },
    {
      "DOI": "10.1136/gutjnl-2015-311098",
      "author": "DK Bartsch",
      "doi-asserted-by": "publisher",
      "first-page": "1314",
      "issue": "8",
      "journal-title": "Gut",
      "key": "70_CR35",
      "unstructured": "Bartsch DK, Slater EP, Carrato A et al (2016) Refinement of screening for familial pancreatic cancer. Gut 65(8):1314–1321. \n                    https://doi.org/10.1136/gutjnl-2015-311098",
      "volume": "65",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1055-9965.epi-10-0374",
      "author": "O Fletcher",
      "doi-asserted-by": "publisher",
      "first-page": "2143",
      "issue": "9",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "70_CR36",
      "unstructured": "Fletcher O, Johnson N, dos Santos Silva I et al (2010) Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev 19(9):2143–2151. \n                    https://doi.org/10.1158/1055-9965.epi-10-0374",
      "volume": "19",
      "year": "2010"
    },
    {
      "author": "P Bretsky",
      "first-page": "733",
      "issue": "8",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "70_CR37",
      "unstructured": "Bretsky P, Haiman CA, Gilad S et al (2003) The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 12(8):733–738",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/djq055",
      "author": "JL Bernstein",
      "doi-asserted-by": "publisher",
      "first-page": "475",
      "issue": "7",
      "journal-title": "J Natl Cancer Inst",
      "key": "70_CR38",
      "unstructured": "Bernstein JL, Haile RW, Stovall M et al. (2010) Radiation exposure, the ATM Gene, and contralateral breast cancer in the women’s environmental cancer and radiation epidemiology study. J Natl Cancer Inst 102(7):475–483. \n                    https://doi.org/10.1093/jnci/djq055",
      "volume": "102",
      "year": "2010"
    },
    {
      "key": "70_CR39",
      "unstructured": "National Comprehensive Cancer Network (NCCN) (2018). Genetic/familial high-risk assessment: breast and ovarian Version 1"
    },
    {
      "DOI": "10.1093/nar/gkv1222",
      "author": "MJ Landrum",
      "doi-asserted-by": "publisher",
      "first-page": "D862",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "70_CR40",
      "unstructured": "Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Hoover J, Jang W, Katz K, Ovetsky M, Riley G, Sethi A, Tully R, Villamarin-Salomon R, Rubinstein W, Maglott DR (2015) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44(D1):D862–D868",
      "volume": "44",
      "year": "2015"
    },
    {
      "key": "70_CR41",
      "unstructured": "National Comprehensive Cancer Network (NCCN) (2017) Genetic/familial high-risk assessment: colorectal Version 3"
    },
    {
      "DOI": "10.1245/s10434-016-5443-5",
      "author": "JC Boughey",
      "doi-asserted-by": "publisher",
      "first-page": "3100",
      "issue": "10",
      "journal-title": "Ann Surg Oncol",
      "key": "70_CR42",
      "unstructured": "Boughey JC, Attai DJ, Chen SL et al (2016) contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks. Ann Surg Oncol 23(10):3100–3105. \n                    https://doi.org/10.1245/s10434-016-5443-5",
      "volume": "23",
      "year": "2016"
    },
    {
      "DOI": "10.1245/s10434-016-5688-z",
      "author": "KK Hunt",
      "doi-asserted-by": "publisher",
      "first-page": "375",
      "issue": "2",
      "journal-title": "Ann Surg Oncol",
      "key": "70_CR43",
      "unstructured": "Hunt KK, Euhus DM, Boughey JC et al. (2017) Society of Surgical Oncology Breast Disease Working Group statement on prophylactic (risk-reducing) mastectomy. Ann Surg Oncol 24(2):375–397. \n                    https://doi.org/10.1245/s10434-016-5688-z",
      "volume": "24",
      "year": "2017"
    },
    {
      "DOI": "10.1245/s10434-007-9447-z",
      "author": "AE Giuliano",
      "doi-asserted-by": "publisher",
      "first-page": "2425",
      "issue": "9",
      "journal-title": "Ann Surg Oncol",
      "key": "70_CR44",
      "unstructured": "Giuliano AE, Boolbol S, Degnim A, Kuerer H, Leitch AM, Morrow M (2007) Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol 14(9):2425–2427. \n                    https://doi.org/10.1245/s10434-007-9447-z",
      "volume": "14",
      "year": "2007"
    },
    {
      "DOI": "10.1245/s10434-008-0160-3",
      "author": "PL Mai",
      "doi-asserted-by": "publisher",
      "first-page": "3415",
      "issue": "12",
      "journal-title": "Ann Surg Oncol",
      "key": "70_CR45",
      "unstructured": "Mai PL, Lagos VI, Palomares MR, Weitzel JN (2008) Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment. Ann Surg Oncol 15(12):3415–3421. \n                    https://doi.org/10.1245/s10434-008-0160-3",
      "volume": "15",
      "year": "2008"
    },
    {
      "DOI": "10.1200/jco.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1055",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "70_CR46",
      "unstructured": "Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062. \n                    https://doi.org/10.1200/jco.2004.04.188",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1200/jco.2007.13.9568",
      "author": "Y Brandberg",
      "doi-asserted-by": "publisher",
      "first-page": "3943",
      "issue": "24",
      "journal-title": "J Clin Oncol",
      "key": "70_CR47",
      "unstructured": "Brandberg Y, Sandelin K, Erikson S et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26(24):3943–3949. \n                    https://doi.org/10.1200/jco.2007.13.9568",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1056/nejm199901143400201",
      "author": "LC Hartmann",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "2",
      "journal-title": "New Engl J Med",
      "key": "70_CR48",
      "unstructured": "Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med 340(2):77–84. \n                    https://doi.org/10.1056/nejm199901143400201",
      "volume": "340",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.ejca.2011.10.020",
      "author": "M den Heijer",
      "doi-asserted-by": "publisher",
      "first-page": "1263-8",
      "issue": "9",
      "journal-title": "Eur J Cancer",
      "key": "70_CR49",
      "unstructured": "den Heijer M, Seynaeve C, Timman R et al (2012) Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer 48(9):1263-8. \n                    https://doi.org/10.1016/j.ejca.2011.10.020",
      "volume": "48",
      "year": "2012"
    },
    {
      "key": "70_CR50",
      "unstructured": "National Institutes of Health (2018) All of Us Research Program"
    },
    {
      "DOI": "10.1002/sim.1668",
      "author": "J Tyrer",
      "doi-asserted-by": "publisher",
      "first-page": "1111",
      "issue": "7",
      "journal-title": "Stat Med",
      "key": "70_CR51",
      "unstructured": "Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111–1130. \n                    https://doi.org/10.1002/sim.1668",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/81.24.1879",
      "author": "MH Gail",
      "doi-asserted-by": "publisher",
      "first-page": "1879",
      "issue": "24",
      "journal-title": "J Natl Cancer Inst",
      "key": "70_CR52",
      "unstructured": "Gail MH, Brinton LA, Byar DP et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886",
      "volume": "81",
      "year": "1989"
    },
    {
      "DOI": "10.1038/gim.2012.167",
      "author": "S Chowdhury",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "issue": "6",
      "journal-title": "Genet Med",
      "key": "70_CR53",
      "unstructured": "Chowdhury S, Dent T, Pashayan N et al. (2013) Incorporating genomics into breast and prostate cancer screening: assessing the implications. Genet Med 15(6):423–432. \n                    https://doi.org/10.1038/gim.2012.167",
      "volume": "15",
      "year": "2013"
    }
  ],
  "reference-count": 53,
  "references-count": 53,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-018-0070-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}